PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE ASTROCYTOMA IN ADULTS

被引：0
|
作者：
Wu, Jing [1 ]
Bryla, Christine [1 ]
Su, Yu-Ting [1 ]
Grajkowska, Ewa [1 ]
McCoy, Ann [2 ]
Boris, Lisa [1 ]
Antony, Ramya [1 ]
Garren, Nancy [2 ]
Siegel, Christine [1 ]
Cordova, Christine [1 ]
Aboud, Orwa [1 ]
Vera, Elizabeth [1 ]
Lawhon, Tracy [3 ]
Penas-Prado, Marta [1 ]
Theeler, Brett [1 ]
Mendoza, Tito [4 ]
Armstrong, Terri [1 ]
Yuan, Ying [4 ]
Gilbert, Mark [1 ]
机构：
[1] NCI, Neurooncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] NCI, Bethesda, MD 20892 USA
[3] Adastra Pharmaceut Inc, San Diego, CA USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ACTR-62
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [1] PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA AND GLIOBLASTOMA
    Wu, Jing
    Bryla, Christine
    Mccoy, Ann
    Lisa, Boris
    Garren, Nancy
    Siegel, Christine
    Grajkowska, Ewa
    Theeler, Brett
    Park, Deric M.
    Parrott, Tracy
    Armstrong, Terri S.
    Yuan, Ying
    Gilbert, Mark R.
    NEURO-ONCOLOGY, 2017, 19 : 15 - 15
  • [2] Phase I trial of TG02 plus dose-dense or metronomic temozolomide for recurrent anaplastic astrocytoma and glioblastoma in adults.
    Wu, Jing
    Yuan, Ying
    Cordova, Christine
    Aboud, Orwa
    Penas-Prado, Marta
    Theeler, Brett James
    Bryla, Christine
    Su, Yu-Ting
    Grajkowska, Ewa
    McCoy, Ann
    Boris, Lisa
    Siegel, Christine
    Antony, Ramya
    Garren, Nancy
    Lawhon, Tracy
    Armstrong, Terri
    Gilbert, Mark R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
    Abacioglu, Ufuk
    Caglar, Hale B.
    Yumuk, Perran F.
    Akgun, Zuleyha
    Atasoy, Beste M.
    Sengoz, Meric
    JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (03) : 585 - 593
  • [4] Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
    Ufuk Abacioglu
    Hale B. Caglar
    Perran F. Yumuk
    Zuleyha Akgun
    Beste M. Atasoy
    Meric Sengoz
    Journal of Neuro-Oncology, 2011, 103 : 585 - 593
  • [5] VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL
    Peters, Katherine B.
    Reardon, David A.
    Vredenburgh, James J.
    Desjardins, Annick
    Herndon, James E., II
    Coan, April
    McSherry, Frances
    Lipp, Eric
    Brickhouse, Alise
    Massey, Woody
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2012, 14 : 81 - 81
  • [6] Dose-dense temozolomide for recurrent high-grade gliomas: a single-center retrospective study
    Catherine R. Garcia
    Stacey A. Slone
    Rachael M. Morgan
    Lindsey Gruber
    Sameera S. Kumar
    Donita D. Lightner
    John L. Villano
    Medical Oncology, 2018, 35
  • [7] Dose-dense temozolomide for recurrent high-grade gliomas: a single-center retrospective study
    Garcia, Catherine R.
    Slone, Stacey A.
    Morgan, Rachael M.
    Gruber, Lindsey
    Kumar, Sameera S.
    Lightner, Donita D.
    Villano, John L.
    MEDICAL ONCOLOGY, 2018, 35 (10)
  • [8] Phase I Clinical Study of a Multi-Kinase Inhibitor TG02 Capsule for the Treatment of Recurrent High-Grade Gliomas with Failed Temozolomide Treatment in Chinese Patients
    Guo, Cheng-cheng
    Yang, Qun-ying
    Xi, Shao-yan
    Zhou, Jian
    Zhou, Zhi-huan
    Cao, Xi
    Liao, Yi-xiang
    Li, Benjamin Xiao-yi
    Dai, Xiang-rong
    Wong, Michael
    Li, Yu-jie
    Yu, Xiao-hui
    Chen, Zhong-ping
    CHEMOTHERAPY, 2024,
  • [9] Phase I study of Gliadel™ wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas
    Gururangan, S
    Cokgor, I
    Rich, JN
    Edwards, S
    Affronti, ML
    Quinn, JA
    Herndon, JE
    Provenzale, JM
    McLendon, RE
    Tourt-Uhlig, S
    Sampson, JH
    Stafford-Fox, V
    Zaknoen, S
    Early, M
    Friedman, AH
    Friedman, HS
    NEURO-ONCOLOGY, 2001, 3 (04) : 246 - 250
  • [10] PHASE II TRIAL OF DOSE-DENSE 1 WEEK ON/1 WEEK OFF TEMOZOLOMIDE FOR PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
    Han, Seunggu
    Molinaro, Annette
    Berger, Mitchel
    Prados, Michael
    Chang, Susan
    Clarke, Jennifer
    Butowski, Nicholas
    NEURO-ONCOLOGY, 2013, 15 : 111 - 111
12345